THE HAGUE – Travel Health Group (THG) has acquired Moustifluid, a French brand for musquito repellants, from Laboratoire Gifrer. The acquisition is in line with the European growth strategy of the Travel Health Group. The Netherlands based company is market leader in the field of anti-insect products and travel health care innovations with its Care Plus Anti-Insect brand.

Moustifluid is a renowned brand that is available in more than twenty thousand pharmacies in France. The range consists of various insect repellent products for the skin, but also insect repellent bracelets and patches. “We are pleased to be reporting on the acquisition of Moustifluid during these times. With this beautiful brand, we have managed to get access to French pharmacies, ” said Arnoud Aalbersberg, co-founder and CEO of the Travel Health Group, after finalizing the acquisition, that took place via an international video conference.

“Conquering the French pharmacy market from the Netherlands is a challenge, but with a trusted brand like Moustifluid we are making a great entrance.” THG will optimize Moustifluid products with formulations that are not yet available in France, such as a 2:1 product (sun protection and mosquito repellant). In addition to the European countries where THG is already active, the brand will also be introduced in French-speaking countries outside Europe. Moustifluid will co-exist within the THG portfolio alongside Care Plus. Product management and sales are run from the Dutch head office, located in Almere.

Laboratory Gifrer
Laboratoire Gifrer was founded in 1912 as a pharmaceutical laboratory and was acquired in 2000 by Qualiphar, a Belgian pharmaceutical family company with headquarters in Bornem. Gifrer has become a main player in supplying pharmaceuticals and health products to pharmacies, hospitals and pharmaceutical wholesalers in France. Gifrer mainly focuses on products for babies, mothers and families. Marc Verlinden, CEO of Gifrer: “Insect repellents have no focus for Gifrer. The sale of our Moustifluid brand to Travel Health Group is a logical choice, since they are the known specialist in this field in Europe.”

Travel Health Group
Safe Travels, Great Stories. That has been the Travel Health Group’s mission since 1989. With information, education and products, Travel Health Group ensures travelers to travel carefree (far away and nearby) and allows them to come home with beautiful stories. The higher goal is a malaria-free world by 2030. To achieve this 1% of the revenue is allocated. The Travel Health Group is a company held by BB Capital Investments

BB Capital Investments
BB Capital Investments is an investment company located in The Hague. As an AFM-registered fund manager, in 2019 BB Capital Investments has launched a fund-of-funds under the motto “Private Equity made easy”. In addition, BB Capital focuses on direct investments and private funds for private investments in growing SMEs with an international focus. The investors of BB Capital Investments mainly consist of Dutch entrepreneurs and wealthy families.